Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinoma
Background: Few overlaps between prognostic biomarkers are observed among different independently performed genomic studies of esophageal squamous cell carcinoma (ESCC). One of the reasons for this is the insufficient cohort size. How many cases are needed to prognostic genes analysis in ESCC?Method...
Main Authors: | Linghong Kong, Ming Yang, Zhiyi Wan, Lining Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Pathology and Oncology Research |
Subjects: | |
Online Access: | https://www.por-journal.com/articles/10.3389/pore.2023.1610909/full |
Similar Items
-
A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay
by: Yuan-Bin Chen, et al.
Published: (2016-08-01) -
Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma
by: Ji-Feng Feng, et al.
Published: (2014-01-01) -
The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study
by: Xiangwei Zhang, et al.
Published: (2017-01-01) -
Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma
by: Kai Xiong, et al.
Published: (2022-04-01) -
Prognostic value of esophageal cancer immune prognostic index in advanced esophageal squamous cell carcinoma patients with anti‐programmed cell death‐1 therapy
by: Jiangyue Lu, et al.
Published: (2023-05-01)